Neoadjuvant androgen ablation before radical prostatectomy reduces positive margin rate, but has no effect on 36-month post-treatment biochemical failure.
Steiner
M S
MS
D000728:Androgens / Q000627:therapeutic use*; D017115:Catheter Ablation; D006801:Humans; D008297:Male; D020360:Neoadjuvant Therapy; D017063:Outcome Assessment, Health Care; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000378:metabolism* / Q000628:therapy*; D016032:Randomized Controlled Trials as Topic; D013997:Time Factors
D000728:Androgens